Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berezné

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Presse Medicale (Paris, France : 1983)|October 7, 2005
[Intravenous immunoglobulins: therapeutic indications]L Mouthon, A Berezné, V Le Guern, et al.
Revue Des Maladies Respiratoires|November 23, 2007
[Interstitial lung disease in systemic sclerosis]L Mouthon, A Berezné, M Brauner, et al.
Annals of the Rheumatic Diseases|May 28, 2008
Risk factors for major infections in Wegener granulomatosis: analysis of 113 patientsC Charlier, C Henegar, O Launay, et al.
La Revue De Medecine Interne|March 12, 2011
[Complaints, needs of patients with systemic sclerosis: a better understanding for a better care]S Morell-Dubois, G Condette-Wojtasik, P Clerson, et al.
Annals of the Rheumatic Diseases|June 15, 2007
Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patientsL Teixeira, L Mouthon, A Mahr, et al.
Transfusion Medicine (Oxford, England)|June 13, 2006
Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two casesA Berezné, N Stieltjes, V Le-Guern, et al.
Medecine Et Maladies Infectieuses|March 24, 2009
Factors influencing influenza-vaccination in adults under immunosuppressive therapy for a systemic inflammatory diseaseF Lanternier, C Henegar, L Mouthon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 23, 2016
Rituximab as first-line therapy for acquired haemophilia A: a single-centre 10-year experienceB Rossi, P Blanche, V Roussel-Robert, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Presse Medicale (Paris, France : 1983)|October 7, 2005
[Intravenous immunoglobulins: therapeutic indications]L Mouthon, A Berezné, V Le Guern, et al.
Revue Des Maladies Respiratoires|November 23, 2007
[Interstitial lung disease in systemic sclerosis]L Mouthon, A Berezné, M Brauner, et al.
Annals of the Rheumatic Diseases|May 28, 2008
Risk factors for major infections in Wegener granulomatosis: analysis of 113 patientsC Charlier, C Henegar, O Launay, et al.
La Revue De Medecine Interne|March 12, 2011
[Complaints, needs of patients with systemic sclerosis: a better understanding for a better care]S Morell-Dubois, G Condette-Wojtasik, P Clerson, et al.
Annals of the Rheumatic Diseases|June 15, 2007
Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patientsL Teixeira, L Mouthon, A Mahr, et al.
Transfusion Medicine (Oxford, England)|June 13, 2006
Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two casesA Berezné, N Stieltjes, V Le-Guern, et al.
Medecine Et Maladies Infectieuses|March 24, 2009
Factors influencing influenza-vaccination in adults under immunosuppressive therapy for a systemic inflammatory diseaseF Lanternier, C Henegar, L Mouthon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 23, 2016
Rituximab as first-line therapy for acquired haemophilia A: a single-centre 10-year experienceB Rossi, P Blanche, V Roussel-Robert, et al.
Pageof 1